Saurabh Saha at Endpoints News' #BIO19
On the heels of $250M launch, Centessa barges ahead with an IPO to fuel its 10-in-1 Medicxi pipeline
Francesco De Rubertis made no secret of IPO plans for Centessa, his 10-in-1 legacy play. Barely two months later, the S-1 is in. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
